Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is among the most common human malignancies. METHODS: In order to provide better understanding of the molecular biology of ccRCC and to identify potential diagnostic/prognostic biomarker and therapeutic targets, we utilized a microarray to profile...

Descripción completa

Detalles Bibliográficos
Autores principales: Schrödter, Sarah, Braun, Martin, Syring, Isabella, Klümper, Niklas, Deng, Mario, Schmidt, Doris, Perner, Sven, Müller, Stefan C, Ellinger, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736613/
https://www.ncbi.nlm.nih.gov/pubmed/26831905
http://dx.doi.org/10.1186/s12943-016-0495-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736613/
https://www.ncbi.nlm.nih.gov/pubmed/26831905
http://dx.doi.org/10.1186/s12943-016-0495-5

Ejemplares similares